Home › Chronic Progressive Multiple Sclerosis › North Carolina
Chronic Progressive Multiple Sclerosis clinical trials in North Carolina
4 studies for Chronic Progressive Multiple Sclerosis are looking for participants at sites in North Carolina.
Cities in North Carolina
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- Velocity Clinical Research, Raleigh Neurology, Raleigh
RecruitingPhase 3
Ages 18 to 60 · All sexes · Updated Nov 10, 2026 · NCT07067463A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
- Local Institution - Site 101, Raleigh
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Oct 30, 2026 · NCT07840326A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Atrium Health, Charlotte
- Velocity Clinical Research, Raleigh
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Oct 13, 2026 · NCT07225504Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
- Duke University, Durham
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Sep 21, 2026 · NCT07477639From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.